Ivey Business School (Canada)
-
Cafe Xaragua: The Calgary Opportunity
Elizabeth M.A. Grasby; Karim MashnukCase IVEY-9B13B004-EAccounting and Control, Entrepreneurship, StrategyAfter one year of operations, a young entrepreneur and his two partners must evaluate a decision that will change the scope and direction of their business, an online retail store that sells fair-trade coffee beans imported from a developing country. An oStarting at €8.20
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Eli Lilly in India: Rethinking the Joint Venture Strategy (Spanish version)
Charles Dhanaraj; Paul W. Beamish; Nikhil CellyCase IVEY-9B04MS16StrategyEli Lilly and Company es una compañía líder en farmacéutica de Los Estados Unidos. El nuevo Presidente de operaciones intercontinentales es reevaluando todas las divisiones de la empresa, incluyendo la empresa conjunta con Ranbaxy Laboratories Limited, una de las empresas farmacéuticas más grandes de la India. Esta estrategia conjunta ha funcionado sin problemas durante varios años a pesar de sus diferencias de enfoque, pero recientemente Ranbaxy...Starting at €8.20
-
The Good Night Motel
Richard H. Mimick; David C. Shaw; Elizabeth M.A. Grasby; Raymond W. LeducCase IVEY-9B12B014-EAccounting and ControlThe Good Night Motel is considering offering special pricing for a two-day church convention event involving 20 rooms. This requires the owner to perform contribution analysis, sensitivity analysis, and some qualitative analysis.Starting at €8.20
-
Barry's Batting Cages Ltd.
Elizabeth M.A. Grasby; Karim MashnukCase IVEY-9B13B005-EAccounting and ControlIn 2012, the owner of a popular batting cage reveals financial details about her company’s long-lived assets for the purpose of completing the necessary fiscal-year accounting transactions.Starting at €8.20
-
Wilshire Sports Importers Ltd.
Elizabeth M.A. Grasby; Karim MashnukCase IVEY-9B13B013-EAccounting and ControlThe sole shareholder and manager of a premier soccer cleat retailer/wholesaler must analyze his company's 2010 performance. The company had experienced significant growth during the past two years and the manager was anxious to find out if the company's recent expansion was as profitable as he had predicted.Starting at €8.20
-
Everything Rattan Inc.
John F. Graham; Anne M. Martin; David C. Shaw; Elizabeth M.A. GrasbyCase IVEY-9B12N008-EFinanceEverything Rattan has approached its bank for a loan. The bank needs to analyze the loan request and prepare a collateral analysis for the situation.Starting at €8.20
-
John Gilbert
David C. ShawCase IVEY-9B13N009-EFinanceA retiring professor must establish a comprehensive financial plan that enables him and his wife to achieve their target lifestyle. In preparing this plan, they devise a budget and a travel agenda and then determine whether they can achieve these outlays and, if so, what risks are involved and how they might manage these risks. They must consider the optimal mix of debt and equity, domestic and foreign currencies, and short- and long-term debt is...Starting at €8.20
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20